Order Article Reprints

Lee W, Park Y, Kwon JW, Jun E, Song KB, Lee JH, Hwang DW, Yoo C, Kim K-p, Jeong JH, et al. Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer. Journal of Clinical Medicine. 2020; 9(5):1477. https://doi.org/10.3390/jcm9051477

Lee, Woohyung, Yejong Park, Jae Woo Kwon, Eunsung Jun, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Jae Ho Jeong, and et al. 2020. "Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer" Journal of Clinical Medicine 9, no. 5: 1477. https://doi.org/10.3390/jcm9051477

Lee, W., Park, Y., Kwon, J. W., Jun, E., Song, K. B., Lee, J. H., Hwang, D. W., Yoo, C., Kim, K.-p., Jeong, J. H., Chang, H.-M., Ryoo, B.-Y., Park, S. Y., & Kim, S. C. (2020). Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer. Journal of Clinical Medicine, 9(5), 1477. https://doi.org/10.3390/jcm9051477